Amgen Inc. (AMG.DE)
Develops and sells medicines that treat cancer, autoimmune diseases, and bone conditions.
345.40+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+35.3%
The outlook
Amgen is trading near its 52-week highs, well above both its 50- and 200-day moving averages, suggesting sustained upward momentum over recent months. The stock carries a trailing P/E of 27.3, and analyst coverage leans constructively toward the company. At current levels, the stock sits near the upper end of its recent trading range.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range97% of the way from its 52-week low to high
Market cap
$186.42B
52-wk high
349.45
52-wk low
230.00
50-day avg
307.71
200-day avg
296.33
Trailing P/E
27.3